INTRODUCTION
============

There are many reports of the harmful effects of proteinuria in pregnancy in relation to hypertension and preeclampsia \[[@b1-kjim-2016-025],[@b2-kjim-2016-025]\]. The dipstick test, which can be used for semiquantitative determination of protein concentration in spot urine, is used as a screening test to detect significant proteinuria. Many pregnant women have random urine dipsticks positive for proteinuria, and there is minimal data on the impact of random urine proteinuria in pregnancy. The gold standard for measuring proteinuria is a 24-hour urine sample for total protein level \[[@b3-kjim-2016-025]\], but this method may result in delayed diagnosis and treatment or possibly a prolonged hospital stay \[[@b4-kjim-2016-025]\]. Several studies have suggested an acceptable correlation between single-voided protein-to-creatinine ratio and 24-hour urine protein in pregnancy \[[@b5-kjim-2016-025],[@b6-kjim-2016-025]\]. However, the impact of random urine proteinuria on pregnancy has not yet been determined. The present study aimed to evaluate random proteinuria as a predictor for the maternal and fetal outcomes of pregnancy.

METHODS
=======

Ethics statement
----------------

This study was approved by the Institutional Review Board (IRB) of Chonnam National University Hospital, Gwangju, Republic of Korea. The study was performed in accordance with the Helsinki Declaration of 1975, as revised in 2000. Each patient in the current study was informed about data usage for this investigation. However, because this study was a retrospective medical record- based study and the study subjects were de-identified, the IRB waived the need for written consent from the patients.

Subjects
--------

This study retrospectively analyzed data from all the pregnant women admitted to the obstetrics department of Chonnam National University Hospital from January 2008 to December 2010. Measurement of urine protein was done by spectrophotometry (Clinitek Novus, Siemens, Munich, Germany). Patients' medical records were used to obtain demographic data; gestational age on admission; gravidity; and history of diabetes, chronic hypertension, and other medical disorders.

Definitions and measurements
----------------------------

Proteinuria was classified by semiquantitative measurements as dipstick positive or negative. Preeclampsia was defined as the onset of hypertension and proteinuria after 20 weeks of gestation in previously normotensive women \[[@b7-kjim-2016-025]\]. Eclampsia was defined as the occurrence of a new-onset seizure in a patient with preeclampsia. Chronic hypertension patients were defined as patients with anti-hypertension medication or systolic blood pressure ≥ 140 mmHg before gestational week 20. Chronic kidney disease was defined as abnormalities of kidney structure or function, present for \> 3 months before pregnancy \[[@b8-kjim-2016-025]\]. The estimated glomerular filtration rate (eGFR) was calculated by The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. The definition of chronic kidney disease (CKD) was taken from the guidelines published by the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative \[[@b9-kjim-2016-025]\]. Other adverse conditions were evaluated, consisting of maternal complications (preterm birth history, abortion, preterm labor, premature rupture of membranes \[PROM\]), fetal complications (intrauterine growth restriction \[IUGR\], intrauterine fetal death, neonatal death), and abnormal maternal laboratory testing (hemoglobin, albumin, blood urea nitrogen, hematuria). Neonatal death was defined as death before discharge from the hospital. Infant weight was deemed normal if greater than 2.5 kg \[[@b9-kjim-2016-025]\]. Abortion was defined as the termination of pregnancy before 20 weeks of gestation \[[@b10-kjim-2016-025]\].

Statistical analysis
--------------------

Data are presented as mean ± standard deviation, median (range), or number (%). Baseline characteristics of the cohort are described using parametric methods for continuous variables and nonparametric methods for categorical variables. The Student *t* test and Pearson chi-square test (or Fisher exact test) were used to compare baseline characteristics for categorical outcomes. The receiver operating characteristic (ROC) curve analysis was performed to investigate the diagnostic performance of any marker. To address potential sources of bias or confounding variables in this observational study, adjustments were made with propensity score matching using maternal age and gestational age.

All analyses were conducted using the SPSS version 21.0 (IBM Co., Armonk, NY, USA). A paired Student *t* test was used to analyze the comparative results.

RESULTS
=======

A total of 2,822 pregnant women were enrolled, and 536 of them had proteinuria. The patients' mean age was 33.0 ± 4.7 years, gestational age was 235.6 ± 50.6 days, and body mass index was 25.9 ± 4.2 at the time of admission. Past obstetric history revealed full term deliveries in 1,609 patients (56.9%). Hypertension had previously been diagnosed in 67 patients (2.4%) and chronic kidney disease in 29 patients (1.0%) ([Table 1](#t1-kjim-2016-025){ref-type="table"}).

Eight hundred and nine women (28.6%) had a history of an artificial abortion, and 617 women (21.9%) had a history of a spontaneous abortion. The mean creatinine concentration of the 2,822 women was 0.5 ± 0.4 mg/dL, and the mean eGFR was 128 ± 14 mL/min/1.73 m^2^. A total of 536 women (19.0%) showed dipstick positive proteinuria (1+, 210 women \[7.4%\]; 2+, 205 women \[7.3%\]; 3+, 121 women \[4.3%\]). A total of 249 women (8.8%) showed hematuria on a urine dipstick test ([Table 2](#t2-kjim-2016-025){ref-type="table"}).

[Table 3](#t3-kjim-2016-025){ref-type="table"} shows the demographic and functional data of patients with and without proteinuria after propensity score matching with age and gestational age at delivery. The proteinuria group shows a higher rate of previous preeclampsia and a lower rate of past full term deliveries. The prevalence of diabetes mellitus and CKD was higher in the proteinuria group. Serum albumin levels and eGFR were lower in the proteinuria group, and blood urea nitrogen levels, serum creatinine levels, and the incidence of hematuria was higher in the proteinuria group ([Table 3](#t3-kjim-2016-025){ref-type="table"}).

[Table 4](#t4-kjim-2016-025){ref-type="table"} shows the clinical outcomes of patients with and without proteinuria. Fetal body weight trended lower in the proteinuria group. The incidence of preterm labor, PROM, IUGR, and preeclampsia was higher in the proteinuria group.

Preeclampsia was the outcome most significantly with proteinuria (Pearson correlation, correlation coefficient = 85%, *p* \< 0.001). Thus, we performed ROC analysis of proteinuria for the predictive value of preeclampsia. The area of the ROC curve was 0.783 (*p* \< 0.001) in propensity score matching samples ([Fig. 1A](#f1-kjim-2016-025){ref-type="fig"}) and 0.851 (*p* \< 0.001) in unmatched whole samples ([Fig. 1B](#f1-kjim-2016-025){ref-type="fig"}).

[Table 5](#t5-kjim-2016-025){ref-type="table"} shows the clinical outcomes of patients before and after gestational week 20 showing proteinuria. Fetal body weight was significantly lower in the proteinuria before gestational week 20 group. Abortion and neonatal fetal death rate also showed significantly higher in the proteinuria before gestational week 20, but preeclampsia was higher in the proteinuria after gestational week 20 group.

DISCUSSION
==========

This study shows that approximately one in five women have dipstick positive proteinuria at some time during their pregnancy. Our data suggest that random urine proteinuria during pregnancy was correlated with preterm labor, PROM, IUGR, and preeclampsia. Some studies have found that maternal and perinatal morbidity and mortality increased with the amount of proteinuria \[[@b11-kjim-2016-025]\]. Several methods are available for measuring proteinuria, but 24-hour urine protein excretion has long been regarded as the gold standard. However, this test has some disadvantages such as inconvenience for patients, inaccuracy due to incomplete collection, cost, and delay of diagnosis and management, which makes its wide use difficult for clinicians. For this reason, many investigators have explored simpler and more convenient diagnostic methods to quantify proteinuria. The urine dipstick test is one of the most commonly used screening tests because of its simplicity and low cost. Nevertheless, this method has high rates of false positive and false negative results associated with fluctuations throughout the day due to water intake, exercise, diet, posture, or improperly trained laboratory staff \[[@b12-kjim-2016-025]-[@b14-kjim-2016-025]\]. Therefore, some investigators have explored other means of quantifying proteinuria in a shorter time period and they suggest a 2-hour collection, 4-hour collection, or using the protein-creatinine ratio \[[@b15-kjim-2016-025]-[@b17-kjim-2016-025]\]. The protein to creatinine ratio of a single sample has been shown to correlate significantly with a 24-hour collection for pregnant patients with protein values of less than 1 g in 24 hours, but not for those with protein values above 1 g, in which the variation between the samples was increased \[[@b18-kjim-2016-025],[@b19-kjim-2016-025]\]. However, those studies evaluated the accuracy of dipstick testing for proteinuria compared to 24-hour urine collection and did not evaluate clinical outcomes. It has been recently reported that urine dipstick test results were closely related to urine creatinine concentration, and postpartum urine samples had significantly lower urine creatinine concentration compared to antepartum urine samples. It was likely to show a false positive result in concentrated urine samples with higher urine creatinine concentration for prediction of preeclampsia \[[@b20-kjim-2016-025]\]. Unfortunately, our data did not consider urine creatinine concentration or urine osmolality.

Preeclampsia is a serious complication of pregnancy, and it is vital to diagnose the condition as early as possible. Preeclampsia is defined as the development of hypertension or proteinuria prior to week 20 or the development of both after week 20 in a woman previously having normal blood pressure \[[@b21-kjim-2016-025]\]. Proteinuria is a defining dysfunction of preeclampsia, the degree of which may fluctuate widely over any 24-hour period due to the circadian variation of urinary albumin excretion \[[@b22-kjim-2016-025],[@b23-kjim-2016-025]\]. Some researchers have concluded that the random urine protein to creatinine ratio is not a good predictor of significant proteinuria in patients with preeclampsia \[[@b24-kjim-2016-025],[@b25-kjim-2016-025]\]. Other studies have shown that urine dipstick for protein results correlate poorly with 24-hour urine samples for differentiating patients with no disease or severe disease \[[@b15-kjim-2016-025],[@b26-kjim-2016-025]\]. The results of our study indicate that random urine proteinuria is highly predictive for preeclampsia. This discrepancy with previous study results might be explained by the fact that our center is a university hospital and pregnant women with false-positive random urine dipstick protein tests might have been screened in private clinics before visiting our hospital. Moreover, our study showed proteinuria after gestational week 20 highly associated with preeclampsia compared to proteinuria before gestational week 20 group. However, the pregnant women who showed proteinuria before gestational week 20 associated with lower fetal body weight, higher abortion and neonatal death rate. Those results may be affected by known CKD women who were included in the proteinuria before gestational week 20 group.

The group with random urine positive for proteinuria also showed lower serum albumin values, lower eGFR, and a higher incidence of hematuria. These laboratory findings can explain poor fetal outcomes such as IUGR.

In conclusion, random urine proteinuria during pregnancy was correlated with preterm labor, PROM, and IUGR, and was also highly predictive for preeclampsia.

KEY MESSAGE
===========

1\. During pregnancy, about 20% showed random urine proteinuria.

2\. Random urine proteinuria is associated with preeclampsia, preterm labor, premature rupture of membrane, and intrauterine growth restriction.
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###### 

Baseline characteristics of all pregnant women included in this study

  Characteristic                Value
  ----------------------------- --------------
  Number                        2,822
  Age, yr                       33.0 ± 4.7
  Gestational age, day          235.6 ± 50.6
  Body mass index, kg/m^2^      25.9 ± 4.2
  Obstetrical past history, %   
   Full term                    1,609 (56.9)
   Preterm (\< 37 weeks)        243 (8.6)
   Artificial abortion          809 (28.6)
   Spontaneous abortion         617 (21.9)
  Maternal risk factor          
   Chronic hypertension         67 (2.4)
   Preeclampsia                 38 (1.3)
   Diabetes mellitus            39 (1.4)
   Smoking                      36 (1.3)
   Chronic kidney disease       29 (1.0)

Values are presented as mean ± SD or number (%).

###### 

Laboratory findings of all the pregnant women at the visit

  Variable                     Value
  ---------------------------- ------------
  Number                       2,822
  Hemoglobin, g/dL             11.9 ± 1.6
  Albumin, g/dL                3.5 ± 0.4
  Blood urea nitrogen, mg/dL   8.5 ± 3.0
  Creatinine, mg/dL            0.5 ± 0.4
  eGFR, mL/min/1.73 m^2^       128 ± 14
  Urine protein                536 (19.0)
   1+                          210 (7.4)
   2+                          205 (7.3)
   3+                          121 (4.3)
  Hematuria                    249 (8.8)

Values are presented as mean ± SD or number (%).

eGFR, estimated glomerular filtration rate.

###### 

Comparison of demographic and functional data between two groups

  Variable                      No proteinuria (n = 536)   Proteinuria (n = 536)   *p* value
  ----------------------------- -------------------------- ----------------------- -----------
  Obstetrical past history, %                                                      
   Full term                    248 (46.3)                 172 (32.1)              \< 0.001
   Preterm (\< 37 weeks)        45 (8.4)                   42 (7.8)                0.748
   Artificial arbortion         171 (31.9)                 150 (28.0)              0.520
   Spontaneous arbortion        106 (19.8)                 123 (22.9)              0.493
   Preeclampsia                 4 (0.7)                    19 (3.5)                0.002
  Maternal risk factor                                                             
   Hypertension                 13 (2.4)                   24 (4.5)                0.219
   Diabetes mellitus            5 (0.9)                    14 (2.6)                0.037
   Smoking                      7 (1.3)                    10 (1.9)                0.463
   Chronic kidney disease       1 (0.2)                    28 (5.2)                0.004
  Lab findings                                                                     
   Hemoglobin, g/dL             11.9 ± 1.4                 12.1 ± 1.8              0.042
   Albumin, g/dL                3.5 ± 0.4                  3.3 ± 0.5               \< 0.001
   Blood urea nitrogen, mg/dL   8.0 ± 2.5                  10.5 ± 4.1              \< 0.001
   Creatinine, g/dL             0.5 ± 0.3                  0.6 ± 0.4               \< 0.001
   eGFR, mL/min/1.73 m^2^       130.0 ± 13.0               120.9 ± 19.0            \< 0.001
   Hematuria                    29 (5.4)                   102 (19.0)              \< 0.001

Values are presented as number (%) or mean ± SD.

eGFR, estimated glomerular filtration rate.

###### 

Clinical outcomes of proteinuria

  Variable                No proteinuria (n = 536)   Proteinuria (n = 536)   *p* value
  ----------------------- -------------------------- ----------------------- -----------
  Fetal body weight       2,458 ± 912                2,360 ± 974             0.089
  Full term               240 (44.8)                 234 (43.7)              0.712
  Preterm (\< 37 weeks)   257 (47.9)                 255 (47.6)              0.903
  Preterm labor           65 (12.1)                  105 (19.6)              0.001
  Abortion                14 (2.6)                   15 (2.8)                0.851
  Neonatal death          38 (7.1)                   46 (8.6)                0.363
  PROM                    74 (13.8)                  123 (22.9)              \< 0.001
  IUGR                    48 (9.0)                   78 (14.6)               0.004
  IUFD                    11 (2.1)                   19 (3.5)                0.138
  Preeclampsia            14 (2.6)                   222 (41.4)              \< 0.001
  Eclampsia               0                          2 (0.4)                 0.157
  GDM                     20 (3.7)                   28 (5.2)                0.237

Values are presented as mean ± SD or number (%).

PROM, preterm rupture of membrane; IUGR, intrauterine growth restriction; IUFD, intrauterine fetal death; GDM, gestational diabetes mellitus.

###### 

Clinical outcomes between before and after GW 20 showing proteinuria

  Variable                Proteinuria before GW 20 (n = 54)   Proteinuria after GW 20 (n = 482)   *p* value
  ----------------------- ----------------------------------- ----------------------------------- -----------
  Fetal body weight       1,740 ± 1,336                       2,425 ± 908                         0.001
  Full term               16 (29.6)                           216 (44.8)                          0.021
  Preterm (\< 37 weeks)   20 (37.0)                           235 (48.8)                          0.066
  Preterm labor           2 (8.0)                             63 (13.1)                           0.395
  Abortion                15 (27.8)                           0                                   \< 0.001
  Neonatal death          18 (33.3)                           29 (6.0)                            \< 0.001
  PROM                    7 (13.0)                            67 (13.9)                           0.521
  IUGR                    5 (9.3)                             71 (14.7)                           0.188
  IUFD                    0                                   19 (3.9)                            0.128
  Preeclampsia            10 (18.5)                           211 (43.8)                          \< 0.001
  Eclampsia               0                                   2 (0.4)                             0.808
  GDM                     2 (3.7)                             26 (5.4)                            0.448

Values are presented as mean ± SD or number (%).

GW, gestational week; PROM, preterm rupture of membrane; IUGR, intrauterine growth restriction; IUFD, intrauterine fetal death; GDM, gestational diabetes mellitus.
